-
1
-
-
78149247393
-
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications
-
Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 2010; 95(11): 1873-9.
-
(2010)
Haematologica
, vol.95
, Issue.11
, pp. 1873-1879
-
-
Jegalian, A.G.1
Buxbaum, N.P.2
Facchetti, F.3
-
2
-
-
66149123001
-
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia
-
Garnache-Ottou F, Feuillard J, Ferrand C, et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 2009; 145(5): 624-36.
-
(2009)
Br J Haematol
, vol.145
, Issue.5
, pp. 624-636
-
-
Garnache-Ottou, F.1
Feuillard, J.2
Ferrand, C.3
-
3
-
-
43549106155
-
Novel markers of normal and neoplastic human plasmacytoid dendritic cells
-
Marafioti T, Paterson JC, Ballabio E, et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008; 111(7): 3778-92.
-
(2008)
Blood
, vol.111
, Issue.7
, pp. 3778-3792
-
-
Marafioti, T.1
Paterson, J.C.2
Ballabio, E.3
-
4
-
-
0038721478
-
TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin
-
Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003; 101(12): 5007-9.
-
(2003)
Blood
, vol.101
, Issue.12
, pp. 5007-5009
-
-
Herling, M.1
Teitell, M.A.2
Shen, R.R.3
Medeiros, L.J.4
Jones, D.5
-
5
-
-
19944431092
-
Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells
-
Garnache-Ottou F, Chaperot L, Biichle S, et al. Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Blood 2005; 105(3): 1256-64.
-
(2005)
Blood
, vol.105
, Issue.3
, pp. 1256-1264
-
-
Garnache-Ottou, F.1
Chaperot, L.2
Biichle, S.3
-
6
-
-
54249156525
-
Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability
-
Narita M, Kuroha T, Watanabe N, et al. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability. Acta Haematol 2008; 120(2): 91-9.
-
(2008)
Acta Haematol
, vol.120
, Issue.2
, pp. 91-99
-
-
Narita, M.1
Kuroha, T.2
Watanabe, N.3
-
7
-
-
0032773794
-
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
-
Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5: 919-923.
-
(1999)
Nat Med
, vol.5
, pp. 919-923
-
-
Cella, M.1
Jarrossay, D.2
Facchetti, F.3
-
8
-
-
0035865228
-
Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c-type 2 dendritic cell precursors and CD11c+dendritic cells to produce type I IFN
-
Kadowaki N, Antonenko S, Liu YJ. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c-type 2 dendritic cell precursors and CD11c+dendritic cells to produce type I IFN. J Immunol 2001; 166: 2291-2295.
-
(2001)
J Immunol
, vol.166
, pp. 2291-2295
-
-
Kadowaki, N.1
Antonenko, S.2
Liu, Y.J.3
-
9
-
-
1642363341
-
Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts
-
Chaperot L, Perrot I, Jacob MC, et al. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts. Eur J Immunol 2004; 34(2): 418-26.
-
(2004)
Eur J Immunol
, vol.34
, Issue.2
, pp. 418-426
-
-
Chaperot, L.1
Perrot, I.2
Jacob, M.C.3
-
10
-
-
0042123694
-
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells
-
Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198(3): 513-20.
-
(2003)
J Exp Med
, vol.198
, Issue.3
, pp. 513-520
-
-
Lund, J.1
Sato, A.2
Akira, S.3
Medzhitov, R.4
Iwasaki, A.5
-
11
-
-
53449090956
-
A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation
-
Xu LP, Huang XJ, Liu DH, Chen YH, Shi HX, Chen DB. A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation. Zhonghua Nei Ke Za Zhi 2007; 46(12): 996-9.
-
(2007)
Zhonghua Nei Ke Za Zhi
, vol.46
, Issue.12
, pp. 996-999
-
-
Xu, L.P.1
Huang, X.J.2
Liu, D.H.3
Chen, Y.H.4
Shi, H.X.5
Chen, D.B.6
-
12
-
-
73949122748
-
Plasmacytoid dendritic cells: physiologic roles and pathologic states
-
Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol 2009; 16(6): 392-404.
-
(2009)
Adv Anat Pathol
, vol.16
, Issue.6
, pp. 392-404
-
-
Jegalian, A.G.1
Facchetti, F.2
Jaffe, E.S.3
-
13
-
-
0026355685
-
Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression
-
Armitage JM, Kormos RL, Stuart RS, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 1991; 10: 877.
-
(1991)
J Heart Lung Transplant
, vol.10
, pp. 877
-
-
Armitage, J.M.1
Kormos, R.L.2
Stuart, R.S.3
-
14
-
-
72749104723
-
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
-
Dalle S, Beylot-Barry M, Bagot M, et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol 2010; 162(1): 74-9.
-
(2010)
Br J Dermatol
, vol.162
, Issue.1
, pp. 74-79
-
-
Dalle, S.1
Beylot-Barry, M.2
Bagot, M.3
-
15
-
-
79960262495
-
Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity
-
Dietrich S, Andrulis M, Hegenbart U, et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant 2011; 17(8): 1250-4.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, Issue.8
, pp. 1250-1254
-
-
Dietrich, S.1
Andrulis, M.2
Hegenbart, U.3
-
16
-
-
0036625058
-
CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique
-
Leroux D, Mugneret F, Callanan M, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood 2002; 99(11): 4154-9.
-
(2002)
Blood
, vol.99
, Issue.11
, pp. 4154-4159
-
-
Leroux, D.1
Mugneret, F.2
Callanan, M.3
-
17
-
-
79955521122
-
An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder
-
Patel JL, Shetty S, Salama ME. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder. Am J Dermatopathol 2011; 33(3): e31-6.
-
(2011)
Am J Dermatopathol
, vol.33
, Issue.3
-
-
Patel, J.L.1
Shetty, S.2
Salama, M.E.3
-
18
-
-
33846878526
-
Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice
-
Lim WH, Kireta S, Russ GR, Coates PT. Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 2007; 109(3): 1043-50.
-
(2007)
Blood
, vol.109
, Issue.3
, pp. 1043-1050
-
-
Lim, W.H.1
Kireta, S.2
Russ, G.R.3
Coates, P.T.4
-
19
-
-
33746936633
-
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation
-
Sundin M, Le Blanc K, Ringdén O, et al. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Haematologica 2006; 91(8): 1059-67.
-
(2006)
Haematologica
, vol.91
, Issue.8
, pp. 1059-1067
-
-
Sundin, M.1
Le Blanc, K.2
Ringdén, O.3
-
20
-
-
0035015312
-
Identifying the patient at risk for post-transplant lymphoproliferative disorder
-
Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001; 3(2): 70-8.
-
(2001)
Transpl Infect Dis
, vol.3
, Issue.2
, pp. 70-78
-
-
Cockfield, S.M.1
-
21
-
-
0037180930
-
Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation
-
Petit B, Le Meur Y, Jaccard A, et al. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation. Transplantation 2002; 73(2): 265-71.
-
(2002)
Transplantation
, vol.73
, Issue.2
, pp. 265-271
-
-
Petit, B.1
Le Meur, Y.2
Jaccard, A.3
-
22
-
-
0031955678
-
Post-transplantation lymphoproliferative disorder of donor origin in a sex-mismatched renal allograft as proven by chromosome in situ hybridization
-
Cheung AN, Chan AC, Chung LP, Chan TM, Cheng IK, Chan KW. Post-transplantation lymphoproliferative disorder of donor origin in a sex-mismatched renal allograft as proven by chromosome in situ hybridization. Mod Pathol 1998; 11(1): 99-102.
-
(1998)
Mod Pathol
, vol.11
, Issue.1
, pp. 99-102
-
-
Cheung, A.N.1
Chan, A.C.2
Chung, L.P.3
Chan, T.M.4
Cheng, I.K.5
Chan, K.W.6
-
23
-
-
79953236786
-
Association of HLA polymorphism with post-transplant lymphoproliferative disorders in solid-organ transplant recipients
-
Reshef R, Luskin MR, Kamoun M, et al. Association of HLA polymorphism with post-transplant lymphoproliferative disorders in solid-organ transplant recipients. Am J Transplant 2011; 11(4): 517-825.
-
(2011)
Am J Transplant
, vol.11
, Issue.4
, pp. 517-825
-
-
Reshef, R.1
Luskin, M.R.2
Kamoun, M.3
-
24
-
-
77950902491
-
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
-
Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A 2010; 107(14): 6400-5.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.14
, pp. 6400-6405
-
-
Hjalgrim, H.1
Rostgaard, K.2
Johnson, P.C.3
-
25
-
-
79960262495
-
Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity
-
Dietrich S, Andrulis M, Hegenbart U, et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant 2011; 17(8): 1250-4.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, Issue.8
, pp. 1250-1254
-
-
Dietrich, S.1
Andrulis, M.2
Hegenbart, U.3
-
26
-
-
77956912522
-
Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission
-
Male HJ, Davis MB, McGuirk JP, et al. Blastic plasmacytoid dendritic cell neoplasm should be treated with acute leukemia type induction chemotherapy and allogeneic stem cell transplantation in first remission. Int J Hematol 2010; 92(2): 398-400.
-
(2010)
Int J Hematol
, vol.92
, Issue.2
, pp. 398-400
-
-
Male, H.J.1
Davis, M.B.2
McGuirk, J.P.3
-
27
-
-
80053016578
-
Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q
-
Mitteldorf C, Bertsch HP, Baumgart M, et al. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q. J Eur Acad Dermatol Venereol 2011 Oct; 25(10): 1225-9.
-
(2011)
J Eur Acad Dermatol Venereol
, vol.25
, Issue.10
, pp. 1225-1229
-
-
Mitteldorf, C.1
Bertsch, H.P.2
Baumgart, M.3
|